-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cero Therapeutics Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2021 to Q2 2025.
- Cero Therapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$5.42M, a 121% decline year-over-year.
- Cero Therapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$14.1M, a 131% decline year-over-year.
- Cero Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$7.73M, a 6.07% decline from 2023.
- Cero Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.29M, a 992% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)